Theodoros Koutroukides
Theo is co-founder of Atlantic Accelerator Ltd where he currently holds the position of Senior VP, while he is completing his PhD on Schizophrenia biomarkers discovery at the Institute of Biotechnology, Cambridge University, UK.
He is a board member at Cambridge Phenomenon Ltd and has previously held the position of Chairman at the Cambridge University Technology & Enterprise Club (CUTEC).
Theo completed his Biotechnology BSc at Imperial College, London in 2003. For the 5 subsequent years he acquired experience in diverse biomedical technologies through his employment at the White Shark Research Institute in Cape Town, South Africa, and Fox Chase Cancer Center in Philadelphia, USA.
Theodoros Koutroukides is co-founder of Atlantic Accelerator Ltd where he currently holds the position of Senior VP, while he is completing his PhD on S
Theodoros Koutroukides is co-founder of Atlantic Accelerator Ltd where he currently holds the position of Senior VP, while he is completing his PhD on Schizophrenia biomarkers discovery at the Institute of Biotechnology, Cambridge University, UK. Theo is a board member at Cambridge Phenomenon Ltd and has previously held the position of Chairman at the Cambridge University Technology & Enterprise Club (CUTEC).
In 2003, he completed his Biotechnology BSc at Imperial College, London. For the 5 subsequent years he acquired experience in diverse biomedical technologies through his employment at the White Shark Research Institute in Cape Town, South Africa, and Fox Chase Cancer Center in Philadelphia, USA.
chizophrenia biomarkers discovery at the Institute of Biotechnology, Cambridge University, UK. Theo is a board member at Cambridge Phenomenon Ltd and has previously held the position of Chairman at the Cambridge University Technology & Enterprise Club (CUTEC).
In 2003, he completed his Biotechnology BSc at Imperial College, London. For the 5 subsequent years he acquired experience in diverse biomedical technologies through his employment at the White Shark Research Institute in Cape Town, South Africa, and Fox Chase Cancer Center in Philadelphia, USA.
